MoonLake Immunotherapeutics (MLTX)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
19. 68
+0.67
+3.5245%
$
1.61B Market Cap
- P/E Ratio
- Div Yield
726,100 Volume
-1.16 Eps
$ 19.01
Previous Close 
Want to track MLTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
MLTX Earnings Reports FAQ
What is the earnings per share (EPS) for MLTX?
The current EPS is -1.16.
What is the company's earnings growth rate?
MoonLake Immunotherapeutics has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
MoonLake Immunotherapeutics has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for MoonLake Immunotherapeutics are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for MLTX at this time, as MoonLake Immunotherapeutics has no recent EPS data to calculate it.
